Immunopathogenesis of skin injury in systemic lupus erythematosus
- PMID: 33315653
- PMCID: PMC8208233
- DOI: 10.1097/BOR.0000000000000770
Immunopathogenesis of skin injury in systemic lupus erythematosus
Abstract
Purpose of review: Skin injury is the most common clinical manifestation of SLE and is disfiguring, difficult to treat, and incompletely understood. We provide an overview of recently published articles covering the immunopathogenesis of skin injury in SLE.
Recent findings: Skin of SLE has an inherent susceptibility to apoptosis, the cause of which may be multifactorial. Chronic IFN overexpression leads to barrier disruption, infiltration of inflammatory cells, cytokine production, and release of autoantigens and autoantibody production that result in skin injury. Ultraviolet light is the most important CLE trigger and amplifies this process leading to skin inflammation and potentially systemic disease flares.
Summary: The pathogenesis of skin injury in CLE is complex but recent studies highlight the importance of mechanisms driving dysregulated epidermal cell death likely influenced by genetic risk factors, environmental triggers (UV light), and cytotoxic cells and cellular signaling.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
Conflict of Interest: JMK has served on advisory boards for AstraZeneca, Eli Lilly, Bristol Myers Squibb, Avion Pharmaceuticals, Provention Bio, Aurinia Pharmaceuticals, and Boehringer Ingleheim. She has received grant funding from Bristol Myerse Squibb/Celgene and Q32 Bio.
Figures
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
